Where does Simon Goldman work?

Simon Goldman is Partner at AlbionVC.

What does Simon Goldman invest in?

Simon Goldman invests in Biotech, Medical Devices.

What check size does Simon Goldman write?

Simon Goldman typically writes checks of $5M – $10M.

What companies has Simon Goldman invested in?

Investments tracked here include AstronauTx, Epilepsy GTx, EpilepsyGTx, NovalGen, PanAngium.

Where did Simon Goldman go to school?

Simon Goldman studied at University of Cambridge (PhD, Auditory Neuroscience); CFA Institute (CFA Program, Financial Analysis).

Simon Goldman

Investor

Partner at AlbionVC

Cambridge, United Kingdom

Writes $5M – $10M checks · typically $7M

Find your path to Simon

328 people in our graph share verified history with Simon — schools, employers, funds. One of them is your warm intro.

Hannah SealunlockedSimon: together at University of Cambridge (2006–2009)

×10Simon: together at University of Cambridge

Simon: together at AlbionVC

About

Simon Goldman is a Partner at AlbionVC, where he focuses on therapeutics, delivery systems, diagnostics and medical devices. He earned a PhD and completed a postdoc in neuroscience at the University of Cambridge, and previously worked at Goldman Sachs JBWere in Melbourne on Healthcare/Biotech and Portfolio Strategy Research teams. Before joining Albion in 2015, he held several roles in the UK and Australian biotech startup sectors.

Contact· self-published, not guessed

s•••@albion.vcreveal

Invests in

BiotechMedical Devices

Experience

AlbionVCPartnercurrent2015 — present
University of CambridgeFellow Commoner, Economicscurrent2007 — presentQueens' College, Cambridge
University of CambridgePostdoctoral Research Associate2012
University of CambridgePostdoctoral Research Associate2011 — 2012Auditory Psychophysics, Department of Experimental Psychology
AbcodiaGlobal Business Development and Project Management2013 — 2016Cambridge, UK
Victorian Biotechnology Advisory CouncilConsultant2013Melbourne, Australia
University of MelbourneTutor2013Melbourne, Australia

Skills & more

Biochemistry9Biotechnology31

Languages English · Italian

From Simon's professional profile.

Investments

Investor

AstronauTxEpilepsy GTxEpilepsyGTxNovalGenPanAngium

Sources: curated public sources · the firm's website.

Colleagues at AlbionVC

Adam Chirkowski

Investor at AlbionVC

Andrew Elder

Deputy Managing Partner at AlbionVC

Cat McDonald

Writes weekly insights on venture capital and geopolitics

Charlotte Lawrence

Managing Director, Direct Equity at British Business Bank

Christina Theilgaard

Head of IR & Institutional Fundraising at Albion Capital Group

Christina Theilgaard

Head of IR & Institutional Fundraising at AlbionVC

Christoph Ruedig

Investor at AlbionVC

Dave Wascha

Operating Partner at AlbionVC

Network1

Christoph Ruedig

Investor at AlbionVC

Investors connected to Simon in public investor directories — a warm-intro map.

Frequently asked questions

Who is Simon Goldman?: Simon Goldman is a Partner at AlbionVC, where he focuses on therapeutics, delivery systems, diagnostics and medical devices. He earned a PhD and completed a postdoc in neuroscience at the University of Cambridge, and previously worked at Goldman Sachs JBWere in Melbourne on Healthcare/Biotech and Portfolio Strategy Research teams. Before joining Albion in 2015, he held several roles in the UK and Australian biotech startup sectors.
Where does Simon Goldman work?: Simon Goldman is Partner at AlbionVC.
What does Simon Goldman invest in?: Simon Goldman invests in Biotech, Medical Devices.
What check size does Simon Goldman write?: Simon Goldman typically writes checks of $5M – $10M.
What companies has Simon Goldman invested in?: Investments tracked here include AstronauTx, Epilepsy GTx, EpilepsyGTx, NovalGen, PanAngium.
Where did Simon Goldman go to school?: Simon Goldman studied at University of Cambridge (PhD, Auditory Neuroscience); CFA Institute (CFA Program, Financial Analysis).